MorphImmune Inc. 13D and 13G filings for Immunome, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-07-07 08:39 am Purchase | 2023-06-29 | 13D | Immunome, Inc. IMNM | MorphImmune Inc. | 2,659,508 20.000% | 2,659,508 (New Position) | Filing |